Literature DB >> 32381425

Walking Speed and Muscle Mass Estimated by the D3-Creatine Dilution Method Are Important Components of Sarcopenia Associated With Incident Mobility Disability in Older Men: A Classification and Regression Tree Analysis.

Jesse Zanker1, Sheena Patel2, Terri Blackwell2, Kate Duchowny3, Sharon Brennan-Olsen1, Steven R Cummings3, William J Evans4, Eric S Orwoll5, David Scott6, Sara Vogrin1, Jane A Cauley7, Gustavo Duque1, Peggy M Cawthon8.   

Abstract

OBJECTIVES: It is unknown whether muscle mass measured by the D3-creatine dilution method is a superior predictor of incident mobility disability than traditional components of sarcopenia definitions (including grip strength, walking speed, appendicular lean mass). The objective of this study was to determine the relative importance of strength; physical performance; and lean, fat, and muscle mass in predicting incident mobility disability in older men.
DESIGN: Longitudinal cohort study of participants in the Osteoporotic Fractures in Men (MrOS) study. SETTING AND PARTICIPANTS: Muscle mass was assessed by D3-creatine dilution in 1098 men (aged 83.7 ± 3.7 years). Participants also completed anthropomorphic measures, 6-m walking speed (m/s), grip strength (kg), chair stands (seconds), and dual x-ray absorptiometry appendicular lean mass (ALM), and total body fat percentage. Men self-reported incident mobility disability defined by the development of an inability to complete at least one of walking 2-3 blocks, climbing 10 steps, or carrying 10 lb over 2.2 ± 0.3 years.
METHODS: Classification and regression tree analysis was conducted to determine relative variable importance and algorithm cutpoints for predicting incident mobility disability. Given the proximity of walking speed with the primary outcome (mobility disability), analyses were conducted with and without walking speed.
RESULTS: Walking speed followed by D3Cr muscle mass/weight were the most important variables (variable importance: 53% and 12%, respectively) in the prediction of self-reported incident mobility disability. D3Cr muscle mass was the most important variable in predicting incident mobility disability when walking speed was excluded, followed by chair stands (variable importance: 35% and 33%, respectively). Body fat percentage, ALM, and grip strength were not selected as nodes in either analysis and had low or negligible variable importance. CONCLUSIONS AND IMPLICATIONS: This study has provided valuable insights into the importance of different variables in predicting incident mobility disability in older men. Muscle mass by D3Cr may be a key tool for predicting the risk of negative outcomes in older adults in the future, particularly in post-acute and long-term care settings.
Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sarcopenia; aging; mobility; muscle mass; walking speed

Mesh:

Substances:

Year:  2020        PMID: 32381425      PMCID: PMC8057698          DOI: 10.1016/j.jamda.2020.03.017

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  29 in total

1.  Cut Points for Clinical Muscle Weakness Among Older Americans.

Authors:  Kate A Duchowny; Mark D Peterson; Philippa J Clarke
Journal:  Am J Prev Med       Date:  2017-02-09       Impact factor: 5.043

2.  Overview of recruitment for the osteoporotic fractures in men study (MrOS).

Authors:  Janet Babich Blank; Peggy Mannen Cawthon; Mary Lou Carrion-Petersen; Loretta Harper; J Phillip Johnson; Eileen Mitson; Romelia Ramírez Delay
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

3.  International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

Authors:  E Dent; J E Morley; A J Cruz-Jentoft; H Arai; S B Kritchevsky; J Guralnik; J M Bauer; M Pahor; B C Clark; M Cesari; J Ruiz; C C Sieber; M Aubertin-Leheudre; D L Waters; R Visvanathan; F Landi; D T Villareal; R Fielding; C W Won; O Theou; F C Martin; B Dong; J Woo; L Flicker; L Ferrucci; R A Merchant; L Cao; T Cederholm; S M L Ribeiro; L Rodríguez-Mañas; S D Anker; J Lundy; L M Gutiérrez Robledo; I Bautmans; I Aprahamian; J M G A Schols; M Izquierdo; B Vellas
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Establishing the Link Between Lean Mass and Grip Strength Cut Points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference.

Authors:  Peggy M Cawthon; Thomas G Travison; Todd M Manini; Sheena Patel; Karol M Pencina; Roger A Fielding; Jay M Magaziner; Anne B Newman; Todd Brown; Douglas P Kiel; Steve R Cummings; Michelle Shardell; Jack M Guralnik; Linda J Woodhouse; Marco Pahor; Ellen Binder; Ralph B D'Agostino; Xue Quian-Li; Eric Orwoll; Francesco Landi; Denise Orwig; Laura Schaap; Nancy K Latham; Vasant Hirani; Timothy Kwok; Suzette L Pereira; Daniel Rooks; Makoto Kashiwa; Moises Torres-Gonzalez; Joseph P Menetski; Rosaly Correa-De-Araujo; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

Review 5.  Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons.

Authors:  Laura A Schaap; Annemarie Koster; Marjolein Visser
Journal:  Epidemiol Rev       Date:  2012-12-04       Impact factor: 6.222

6.  Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium.

Authors:  Shalender Bhasin; Thomas G Travison; Todd M Manini; Sheena Patel; Karol M Pencina; Roger A Fielding; Jay M Magaziner; Anne B Newman; Douglas P Kiel; Cyrus Cooper; Jack M Guralnik; Jane A Cauley; Hidenori Arai; Brian C Clark; Francesco Landi; Laura A Schaap; Suzette L Pereira; Daniel Rooks; Jean Woo; Linda J Woodhouse; Ellen Binder; Todd Brown; Michelle Shardell; Quian-Li Xue; Ralph B DʼAgostino; Denise Orwig; Greg Gorsicki; Rosaly Correa-De-Araujo; Peggy M Cawthon
Journal:  J Am Geriatr Soc       Date:  2020-03-09       Impact factor: 5.562

Review 7.  Objectively measured physical capability levels and mortality: systematic review and meta-analysis.

Authors:  Rachel Cooper; Diana Kuh; Rebecca Hardy
Journal:  BMJ       Date:  2010-09-09

8.  Dilution of oral D3 -Creatine to measure creatine pool size and estimate skeletal muscle mass: development of a correction algorithm.

Authors:  Mahalakshmi Shankaran; Gregg Czerwieniec; Chancy Fessler; Po-Yin Anne Wong; Salena Killion; Scott M Turner; Marc K Hellerstein; William J Evans
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-04-16       Impact factor: 12.910

9.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

Review 10.  D3 -Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass.

Authors:  William J Evans; Marc Hellerstein; Eric Orwoll; Steve Cummings; Peggy M Cawthon
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-03-21       Impact factor: 12.910

View more
  6 in total

1.  Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement.

Authors:  Lorenzo M Donini; Luca Busetto; Stephan C Bischoff; Tommy Cederholm; Maria D Ballesteros-Pomar; John A Batsis; Juergen M Bauer; Yves Boirie; Alfonso J Cruz-Jentoft; Dror Dicker; Stefano Frara; Gema Frühbeck; Laurence Genton; Yftach Gepner; Andrea Giustina; Maria Cristina Gonzalez; Ho-Seong Han; Steven B Heymsfield; Takashi Higashiguchi; Alessandro Laviano; Andrea Lenzi; Ibolya Nyulasi; Edda Parrinello; Eleonora Poggiogalle; Carla M Prado; Javier Salvador; Yves Rolland; Ferruccio Santini; Mireille J Serlie; Hanping Shi; Cornel C Sieber; Mario Siervo; Roberto Vettor; Dennis T Villareal; Dorothee Volkert; Jianchun Yu; Mauro Zamboni; Rocco Barazzoni
Journal:  Obes Facts       Date:  2022-02-23       Impact factor: 4.807

2.  Factor analysis to determine relative contributions of strength, physical performance, body composition and muscle mass to disability and mobility disability outcomes in older men.

Authors:  Jesse Zanker; Terri Blackwell; Sheena Patel; Kate Duchowny; Sharon Brennan-Olsen; Steven R Cummings; William J Evans; Eric S Orwoll; David Scott; Sara Vogrin; Gustavo Duque; Peggy M Cawthon
Journal:  Exp Gerontol       Date:  2022-01-29       Impact factor: 4.032

3.  CT Muscle Density, D3Cr Muscle Mass, and Body Fat Associations With Physical Performance, Mobility Outcomes, and Mortality Risk in Older Men.

Authors:  Eric S Orwoll; Terri Blackwell; Steven R Cummings; Jane A Cauley; Nancy E Lane; Andrew R Hoffman; Andrew J Burghardt; William J Evans; Peggy M Cawthon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

Review 4.  Role of Cachexia and Fragility in the Patient Candidate for Cardiac Surgery.

Authors:  Calogera Pisano; Daniele Polisano; Carmela Rita Balistreri; Claudia Altieri; Paolo Nardi; Fabio Bertoldo; Daniele Trombetti; Laura Asta; Maria Sabrina Ferrante; Dario Buioni; Calogero Foti; Giovanni Ruvolo
Journal:  Nutrients       Date:  2021-02-05       Impact factor: 5.717

Review 5.  The Effects of Lifestyle and Diet on Gut Microbiota Composition, Inflammation and Muscle Performance in Our Aging Society.

Authors:  Barbara Strasser; Maike Wolters; Christopher Weyh; Karsten Krüger; Andrea Ticinesi
Journal:  Nutrients       Date:  2021-06-15       Impact factor: 5.717

Review 6.  Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?

Authors:  Anna Picca; Riccardo Calvani; Matteo Cesari; Francesco Landi; Roberto Bernabei; Hélio José Coelho-Júnior; Emanuele Marzetti
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.